Polysubstance use and adherence to antiretroviral treatment in the Miami Adult Studies on HIV (MASH) cohort

References

• Azar, P., Wood, E., Nguyen, P., Luma, M., Montaner, J., Kerr, T., & Milloy, M.-J. (2015). Drug use patterns associated with risk of nonadherence to antiretroviral therapy among HIV-positive illicit drug users in a Canadian setting: A longitudinal analysis. BMC Infectious Diseases, 15(1), 193. https://doi.org/https://doi.org/10.1186/s12879-015-0913-0
   PubMed Web of Science ®Google Scholar
• Babor, T. F., Higgins-Biddle, J. C., Saunders, J. B., & Monteiro, M. G. (2001). AUDIT the alcohol Use Disorders Identification test: Guidelines for use in primary health care. World Health Organization.
   Google Scholar
• Been, S. K., Schadé, A., Bassant, N., Kastelijns, M., Pogány, K., & Verbon, A. (2019). Anxiety, depression and treatment adherence among HIV-infected migrants. AIDS Care, 31(8), 979–987. https://doi.org/https://doi.org/10.1080/09540121.2019.1601676
   PubMed Web of Science ®Google Scholar
• Bell Christine, Metsch Lisa R, Vogenthaler Nicholas, Cardenas Gabriel, Rodriguez Allan, Locascio Virginia, Kuper Tamy, Scharf Elizabeth, Marquez Alexandra, Yohannan Mary, del Rio Carlos (2010). Never in care: Characteristics of HIV-infected crack cocaine users in 2 US cities who have never been to outpatient HIV care. JAIDS Journal of Acquired Immune Deficiency Syndromes, 54(4), 376–380. https://doi.org/https://doi.org/10.1097/QAI.0b013e3181d01d31
   PubMed Web of Science ®Google Scholar
• Boyd, J. H., Weissman, M. M., Thompson, W. D., & Meyers, J. K. (1982). Screening for depression in a community sample: Under-standing discrepancies between depression symptom and diagnostic scales. Archives General Psychiatry, 39(10), 1195–1200. https://doi.org/https://doi.org/10.1001/archpsyc.1982.04290100059010
   PubMed Web of Science ®Google Scholar
• Campa, A., Sales Martinez, S., Sherman, K. E. (2016). Cocaine Use and liver Disease Are associated With All-cause Mortality in the Miami Adult Studies in HIV (MASH) cohort. Journal of Drug Abuse, 02(4), 27. https://doi.org/https://doi.org/10.21767/2471-853X.100036
   Google Scholar
• Capella, M. D., Benaiges, I., & Adan, A. (2015). Neuropsychological performance in polyconsumer Men under treatment. Influence of Age of onset of substance Use. Scientific Reports, 5(1), 12038. https://doi.org/https://doi.org/10.1038/srep12038
   PubMedGoogle Scholar
• Carson, L. (2019). Effect of depression and substance abuse on antiretroviral therapy (ART) adherence in men who have sex with men (MSM) of Mexican descent on the US-Mexico border. Retrieved from May 15, 2019, from https://digitallibwashingtonedu/researchworks/bitstream/handle/1773/36438/Carson_washington_0250O_15931pdf?sequence=1&isAllowed=y
   Google Scholar
• Chesney, M. A., Ickovics, J. R., Chambers, D. B., Gifford, A. L., Neidig, J., Zwick, B., & Wu, A. W. (2000). Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: The AACTG adherence instruments. AIDS Care-Psychological and Socio-Medical Aspects of AIDS/HIV, 12 (3), 255–266. https://doi.org/https://doi.org/10.1080/09540120050042891
   PubMed Web of Science ®Google Scholar
• Cohn Susan E., Jiang Hongyu, McCutchan J. Allen, Koletar Susan L., Murphy Robert L., Robertson Kevin R., de St. Maurice Annabelle M., Currier Judith S., Williams Paige L. (2011). Association of ongoing drug and alcohol use with non-adherence to antiretroviral therapy and higher risk of AIDS and death: Results from ACTG 362. AIDS Care, 23(6), 775–785. https://doi.org/https://doi.org/10.1080/09540121.2010.525617
   PubMed Web of Science ®Google Scholar
• Cook Judith A., Grey Dennis D., Burke-Miller Jane K., Cohen Mardge H., Vlahov David, Kapadia Farzana, Wilson Tracey E., Cook Robert, Schwartz Rebecca M., Golub Elizabeth T., Anastos Kathryn, Ponath Claudia, Goparaju Lakshmi, Levine Alexandra M. (2007). Illicit drug use, depression and their association with highly active antiretroviral therapy in HIV-positive women. Drug and Alcohol Dependence, 89(1), 74–81. https://doi.org/https://doi.org/10.1016/j.drugalcdep.2006.12.002
   PubMed Web of Science ®Google Scholar
• Crim, S. M., Tie, Y., Beer, L., Weiser, J., & Dasgupta, S. (2020). Barriers to antiretroviral therapy adherence Among HIV-positive Hispanic and latino Men Who Have Sex with Men – United States, 2015–2019. MMWR. Morbidity and Mortality Weekly Report, 69(40), 1437–1442. https://doi.org/https://doi.org/10.15585/mmwr.mm6940a1
   PubMed Web of Science ®Google Scholar
• Culbert, G. J., Waluyo, A., Wang, M., Putri, T. A., Bazazi, A. R., & Altice, F. L. (2019). Adherence to antiretroviral therapy Among incarcerated persons with HIV: Associations with methadone and perceived safety. AIDS and Behavior, 23(8), 2048–2058. https://doi.org/https://doi.org/10.1007/s10461-018-2344-6
   PubMed Web of Science ®Google Scholar
• Deren Sherry, Cortes Tara, Dickson Victoria Vaughan, Guilamo-Ramos Vincent, Han Benjamin H., Karpiak Stephen, Naegle Madeline, Ompad Danielle C., Wu Bei (2019). Substance Use Among older people living With HIV: Challenges for Health care providers. Frontiers in Public Health, 7, 94. https://doi.org/https://doi.org/10.3389/fpubh.2019.00094
   PubMed Web of Science ®Google Scholar
• Drugs of Abuse Test McKesson-12 (2020). Drug Panel with Adulterants AMP, BAR, BUP, BZO, COC, mAMP/MET, MDMA, MOP300, MTD, OXY, PCP, THC (OX, pH, SG) Urine Sample 25 Tests. Retrieved from May 15, 2019, from https://mms.mckesson.com/product/1101519/McKesson-Brand-16-6125A3
   Google Scholar
• Fawzi, M. C. S., Ng, L., Kanyanganzi, F., Kirk, C., Bizimana, J., Cyamatare, F., & Betancourt, T. S. (2016). Mental Health and Antiretroviral Adherence Among youth living With HIV in Rwanda. Pediatrics, 138(4). https://doi.org/https://doi.org/10.1542/peds.2015-3235
   Google Scholar
• Feldman, M. B., Kepler, K. L., Irvine, M. K., & Thomas, J. A. (2019). Associations between drug use patterns and viral load suppression among HIV-positive individuals who use support services in New York city. Drug and Alcohol Dependence, 197, 15–21. https://doi.org/https://doi.org/10.1016/j.drugalcdep.2018.12.015
   PubMed Web of Science ®Google Scholar
• Fojo Anthony T., Lesko Catherine R., Calkins Keri L., Moore Richard D., McCaul Mary E., Hutton Heidi E., Mathews William C., Crane Heidi, Christopoulos Katerina, Cropsey Karen, Mugavero Michael J., Mayer Kenneth, Pence Brian W., Lau Bryan, Chander Geetanjali (2019). Do symptoms of depression interact with substance Use to affect HIV Continuum of Care outcomes? AIDS and Behavior, 23(3), 580–591. https://doi.org/https://doi.org/10.1007/s10461-018-2269-0
   PubMed Web of Science ®Google Scholar
• Fuster-RuizdeApodaca Maria Jose, Castro-Granell Vanessa, Garin Noé, Laguía Ana, Jaén Ángeles, Iniesta Carlos, Cenoz Santiago, Galindo María José, Raymond Henry F. (2019). Prevalence and patterns of illicit drug use in people living with HIV in Spain: A cross-sectional study. PLoS One, 14(6), e0211252. https://doi.org/https://doi.org/10.1371/journal.pone.0211252
   PubMed Web of Science ®Google Scholar
• Garin Noe, Zurita Beatriz, Velasco Cesar, Feliu Anna, Gutierrez Mar, Masip Montserrat, Mangues M Antonia (2017). Prevalence and clinical impact of recreational drug consumption in people living with HIV on treatment: A cross-sectional study. BMJ Open, 7(1), e014105. https://doi.org/https://doi.org/10.1136/bmjopen-2016-014105
   PubMed Web of Science ®Google Scholar
• Gonzalez, A., Barinas, J., & O’Cleirigh, C. (2011). Substance Use: Impact on adherence and HIV Medical treatment. Current HIV/AIDS Reports, 8(4), 223–234. https://doi.org/https://doi.org/10.1007/s11904-011-0093-5
   PubMedGoogle Scholar
• Gonzalez, A., Mimiaga, M. J., Israel, J., Andres Bedoya, C., & Safren, S. A. (2013). Substance use predictors of poor medication adherence: The role of substance use coping Among HIV-infected patients in opioid dependence treatment. AIDS and Behavior, 17(1), 168–173. https://doi.org/https://doi.org/10.1007/s10461-012-0319-6
   PubMed Web of Science ®Google Scholar
• Grabovac, I., Meilinger, M., Schalk, H., Leichsenring, B., & Dorner, T. E. (2018). Prevalence and associations of illicit drug and polydrug use in people living with HIV in Vienna. Scientific Reports, 8(1), 8046. https://doi.org/https://doi.org/10.1038/s41598-018-26413-5
   PubMedGoogle Scholar
• Grant Bridget F., Goldstein Rise B., Smith Sharon M., Jung Jeesun, Zhang Haitao, Chou Sanchen P., Pickering Roger P., Ruan Wenjun J., Huang Boji, Saha Tulshi D., Aivadyan Christina, Greenstein Eliana, Hasin Deborah S. (2015). The alcohol use disorder and associated disabilities interview schedule-5 (AUDADIS-5): reliability of substance use and psychiatric disorder modules in a general population sample. Drug and Alcohol Dependence, 148, 27–33. https://doi.org/https://doi.org/10.1016/j.drugalcdep.2014.11.026
   PubMed Web of Science ®Google Scholar
• Hou Jianhua, Fu Jiangning, Meng Siyan, Jiang Taiyi, Guo Caiping, Wu Hao, Su Bin, Zhang Tong (2020). Posttraumatic stress disorder and nonadherence to treatment in people living with HIV: A systematic review and meta-analysis. Frontiers in Psychiatry, 11, 834. https://doi.org/https://doi.org/10.3389/fpsyt.2020.00834
   PubMed Web of Science ®Google Scholar
• Iacob, S. A., Iacob, D. G., & Jugulete, G. (2017). Improving the adherence to antiretroviral therapy, a difficult but essential task for a successful HIV treatment – clinical points of view and practical considerations. Frontiers in Pharmacology, 8, 831. https://doi.org/https://doi.org/10.3389/fphar.2017.00831
   PubMed Web of Science ®Google Scholar
• Kader Rehana, Govender Rajen, Seedat Soraya, Koch John Randy, Parry Charles, Andrei Graciela (2015). Understanding the Impact of hazardous and harmful use of alcohol and/or other drugs on ARV adherence and disease progression. PLoS One, 10(5), e0125088. https://doi.org/https://doi.org/10.1371/journal.pone.0125088
   PubMed Web of Science ®Google Scholar
• Mannes Zachary, Burrell II Larry, Ferguson Erin, Zhou Zhi, Lu Huiyin, Somboonwit Charurut, Cook Robert, Ennis Nicole (2018). The association of therapeutic versus recreational marijuana use and antiretroviral adherence among adults living with HIV in Florida. Patient Preference and Adherence, 12, 1363–1372. https://doi.org/https://doi.org/10.2147/PPA.S167826
   PubMed Web of Science ®Google Scholar
• Meade, C. S., Conn, N. A., Skalski, L. M., & Safren, S. A. (2011). Neurocognitive impairment and medication adherence in HIV patients with and without cocaine dependence. Journal of Behavioral Medicine, 34(2), 128–138. https://doi.org/https://doi.org/10.1007/s10865-010-9293-5
   PubMed Web of Science ®Google Scholar
• Mohamed, I. I., Ahmad, H. E. K., Hassaan, S. H., & Hassaan, S. M. (2020). Assessment of anxiety and depression among substance use disorder patients: A case-control study. Middle East Current Psychiatry, 22, 2020. https://doi.org/https://doi.org/10.1186/s43045-020-00029-w
   Google Scholar
• Molina, P. E., Simon, L., Amedee, A. M., Welsh, D. A., & Ferguson, T. F. (2018). Corrigendum: Impact of alcohol on HIV disease pathogenesis, comorbidities and aging: Integrating preclinical and clinical findings. Alcohol and Alcoholism, 53(5), 636. https://doi.org/https://doi.org/10.1093/alcalc/agy043
   PubMedGoogle Scholar
• Montgomery, L., Bagot, K., Brown, J. L., & Haeny, A. M. (2019). The association between marijuana use and HIV continuum of care outcomes: A systematic review. Current HIV/AIDS Reports, 16(1), 17–28. https://doi.org/https://doi.org/10.1007/s11904-019-00422-z
   PubMed Web of Science ®Google Scholar
• Newville, H., Berg, K. M., & Gonzalez, J. S. (2015). The interaction of active substance use, depression, and antiretroviral adherence in methadone maintenance. International Journal of Behavioral Medicine, 22(2), 214–222. https://doi.org/https://doi.org/10.1007/s12529-014-9429-z
   PubMed Web of Science ®Google Scholar
• NIDA. Drug and alcohol use – a significant risk factor for HIV. Retrieved from April 19, 2020, from https://www.drugabuse.gov/related-topics/trends-statistics/infographics/drug-alcohol-use-significant-risk-factor-hiv
   Google Scholar
• NIDA. National Institute on drug abuse 2016-2020 strategic plan. Retrieved from May 30, 2019, from https://wwwdrugabusegov/sites/default/files/2016-2020nidastrategicplanpdf
   Google Scholar
• Okonji, E. F., Mukumbang, F. C., Orth, Z., Vickerman-Delport, S. A., & Van Wyk, B. (2020). Psychosocial support interventions for improved adherence and retention in ART care for young people living with HIV (10–24 years): a scoping review. BMC Public Health, 20(1), 1841. https://doi.org/https://doi.org/10.1186/s12889-020-09717-y
   PubMed Web of Science ®Google Scholar
• Paolillo, E. W., Gongvatana, A., Umlauf, A., Letendre, S. L., & Moore, D. J. (2017). At-risk alcohol use is associated with antiretroviral treatment non-adherence among adults living with HIV/AIDS. Alcoholism: Clinical and Experimental Research, 41(8), 1518–1525. https://doi.org/https://doi.org/10.1111/acer.13433
   PubMed Web of Science ®Google Scholar
• Parsons, J. T., Starks, T. J., Millar, B. M., Boonrai, K., & Marcotte, D. (2014). Patterns of substance use among HIV-positive adults over 50: Implications for treatment and medication adherence. Drug and Alcohol Dependence, 139, 33–40. https://doi.org/https://doi.org/10.1016/j.drugalcdep.2014.02.704
   PubMed Web of Science ®Google Scholar
• Pary, R., Scarff, J. R., Jijakli, A., Tobias, C., & Lippmann, S. (2015). A review of psychostimulants for adults with depression. Federal Practitioner, 32(Suppl. 3), 30S–37S.
   PubMedGoogle Scholar
• Radloff, L. S. (1977). The CES-D scale: A self-report depression scale for research in the general population’. Applied Psychological Measurement, 1(3), 385–401. https://doi.org/https://doi.org/10.1177/014662167700100306
   Web of Science ®Google Scholar
• Ribeiro, Â, Ribeiro, J. P., & von Doellinger, O. (2018). Depression and psychodynamic psychotherapy. Revista Brasileira de Psiquiatria, 40(1), 105–109. https://doi.org/https://doi.org/10.1590/1516-4446-2016-2107
   PubMed Web of Science ®Google Scholar
• Rosen M. I., Black A. C., Arnsten J. H., Goggin K., Remien R. H., Simoni J. M., Golin C. E., Bangsberg D. R., Liu H. (2013). Association between use of specific drugs and antiretroviral adherence: Findings from MACH 14. AIDS and Behavior, 17(1), 142–147. https://doi.org/https://doi.org/10.1007/s10461-011-0124-7
   PubMed Web of Science ®Google Scholar
• Rowell-Cunsolo, T. L., & Hu, G. (2020). Barriers to optimal antiretroviral therapy adherence among HIV-infected formerly incarcerated individuals in New York city. PLoS One, 15(6), e0233842; 1–12. https://doi.org/https://doi.org/10.1371/journal.pone.0233842
   PubMed Web of Science ®Google Scholar
• Smith, A. B., & Cook, P. F. (2019). Comorbid mental health disorders in persons living with HIV: Adherence to antiretroviral therapy. Archives of Psychiatric Nursing, 33(4), 364–370. https://doi.org/https://doi.org/10.1016/j.apnu.2019.04.008
   PubMed Web of Science ®Google Scholar
• Socias, M. E., & Milloy, M. J. (2018). Substance use and adherence to antiretroviral therapy: What is known and what is unknown. Current Infectious Disease Reports, 20(9), 36. https://doi.org/https://doi.org/10.1007/s11908-018-0636-7
   PubMed Web of Science ®Google Scholar
• Spaan, P., van Luenen, S., Garnefski, N., & Kraaij, V. (2020). Psychosocial interventions enhance HIV medication adherence: A systematic review and meta-analysis. Journal of Health Psychology, 25(10–11), 1326–1340. https://doi.org/https://doi.org/10.1177/1359105318755545
   PubMed Web of Science ®Google Scholar
• Stata Corp. Stata statistical software: Version 16. StataCorp LP.
   Google Scholar
• Thaler, N. S., Sayegh, P., Kim, M. S., Castellon, S. A., & Hinkin, C. H. (2015). Interactive effects of neurocognitive impairment and substance use on antiretroviral nonadherence in HIV disease. Archives of Clinical Neuropsychology, 30(2), 114–121. https://doi.org/https://doi.org/10.1093/arclin/acu092
   PubMed Web of Science ®Google Scholar
• Uthman, O. A., Magidson, J. F., Safren, S. A., & Nachega, J. B. (2014). Depression and adherence to antiretroviral therapy in low-, middle- and high-income countries: A systematic review and meta-analysis. Current HIV/AIDS Reports, 11(3), 291–307. https://doi.org/https://doi.org/10.1007/s11904-014-0220-1
   PubMed Web of Science ®Google Scholar
• van Steenbergen, H., Eikemo, M., & Leknes, S. (2019). The role of the opioid system in decision making and cognitive control: A review. Cognitive, Affective, & Behavioral Neuroscience, 19(3), 435–458. https://doi.org/https://doi.org/10.3758/s13415-019-00710-6
   PubMed Web of Science ®Google Scholar